Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy
Submitted by
admin
on February 12, 2025 - 9:39pm
Source:
Yahoo Finance
News Tags:
Roche
Evrysdi
FDA
SMA
Headline:
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy
snippet:
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries
Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and safety as the currently available oral solution
New tablet formulation may provide greater freedom and independence for people with SMA thanks to simplified dose administration
Do Not Allow Advertisers to Use My Personal information
